GlassScriptPhysician profile
Leslie A Shock
NPI 1649628439
$6,593.94
in general payments reported to CMS, 2019-2025
14 companies · $1,104 in 2025
The $1,104 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,938 · 2020: $380 · 2021: $1,460 · 2022: $425 · 2023: $604 · 2024: $683 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,780 · Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,780.40 |
| Food and Beverage | $610.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,200.71 | 2019-2023 | |
| Abbvie INC. | $1,907.82 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Elite Orthopedics, LLC | $1,244.43 | 2021 | |
| Integra Lifesciences Corporation | $410.01 | 2019-2022 | |
| Stryker Corporation | $384.84 | 2019-2022 | |
| Revance Therapeutics, INC. | $101.00 | 2024 | Daxxify |
| Mentor Worldwide LLC | $61.36 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $61.34 | 2019-2020 | |
| Baxter Healthcare | $49.36 | 2019 | |
| Zimmer Biomet Holdings, INC. | $43.75 | 2019 | |
| Axogen | $43.43 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $32.15 | 2019 | |
| Motiva USA, LLC | $27.98 | 2025 | |
| Polynovo North America LLC | $25.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Shock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.